Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis


Creative Commons License

Dhami S., Nurmatov U., Arasi S., Khan T., Asaria M., Zaman H., ...Daha Fazla

ALLERGY, cilt.72, sa.11, ss.1597-1631, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 72 Sayı: 11
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1111/all.13201
  • Dergi Adı: ALLERGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1597-1631
  • Anahtar Kelimeler: allergen, allergen immunotherapy, allergic rhinoconjunctivitis, subcutaneous, sublingual, PLACEBO-CONTROLLED TRIAL, HOUSE-DUST-MITE, SUBLINGUAL-SWALLOW IMMUNOTHERAPY, POLLEN-INDUCED RHINOCONJUNCTIVITIS, RANDOMIZED CONTROLLED-TRIAL, SHORT-TERM IMMUNOTHERAPY, STANDARDIZED 5-GRASS-POLLEN EXTRACT, COST-EFFECTIVENESS ANALYSIS, MONOPHOSPHORYL-LIPID-A, SUMMER HAY-FEVER
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

BackgroundThe European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis. To inform the development of clinical recommendations, we undertook a systematic review to assess the effectiveness, cost-effectiveness, and safety of AIT in the management of allergic rhinoconjunctivitis.